文献速递乳腺介入US

开放手术、真空辅助乳腺活检与高强度聚焦超声治疗乳腺纤维腺瘤的生活质量、美观度及成本-效用比较

A Comparison of Quality of Life, Cosmesis and Cost-Utility of Open Surgery, Vacuum-Assisted Breast Biopsy and High Intensity Focused Ultrasound for Breast Fibroadenoma.
PubMed 文献 · Acad Radiol · 2024-04-18

研究纳入162例患者共267个纤维腺瘤,比较开放手术、真空辅助乳腺活检与高强度聚焦超声治疗后的生活质量、美观度及成本-效用。高强度聚焦超声组在治疗后3个月和6个月的心理健康评分、乳房美观满意度及哈佛量表优良率均最高,且相对开放手术具有成本-效用优势,而真空辅助活检则无成本-效用优势。三种治疗均有效且安全。

要点

  • 高强度聚焦超声组乳房美观满意度96.49%,高于真空辅助活检组54.90%和开放手术组49.99%。
  • 哈佛量表优良率:高强度聚焦超声组100.00%,真空辅助活检组78.42%,开放手术组27.78%。
  • 高强度聚焦超声组治疗后3个月和6个月的心理健康评分显著高于其他两组。

核心结论

  • 开放手术、真空辅助活检和高强度聚焦超声治疗纤维腺瘤均有效且安全,但高强度聚焦超声在生活质量改善、乳房美观度和成本-效用方面最优。

研究设计与样本

  • 研究纳入162例患者共267个纤维腺瘤,记录基线特征和治疗信息,于治疗后3、6、12个月随访。
  • 生活质量采用健康调查评估,乳房美观度采用自评调查和哈佛量表评估。
  • 建立决策分析模型并计算增量成本以进行成本-效用分析。

诊断标准与关键数值

  • 生活质量评估中,三组躯体健康评分无差异(P > 0.05),高强度聚焦超声组心理健康评分在治疗后3个月和6个月显著高于其他两组(P < 0.05)。
  • 乳房美观满意度:高强度聚焦超声组96.49%,真空辅助活检组54.90%,开放手术组49.99%(P < 0.05)。
  • 哈佛量表评分为优良的患者比例:开放手术组27.78%,真空辅助活检组78.42%,高强度聚焦超声组100.00%(P < 0.05)。
  • 获得一个质量调整生命年的成本:开放手术1034.31美元,真空辅助活检1776.96美元,高强度聚焦超声1277.67美元。
  • 与开放手术相比,增量成本分析显示高强度聚焦超声具有成本-效用,而真空辅助活检不具有成本-效用。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To compare the quality of life (QOL), cosmesis and cost-utility of open surgery (OS), vacuum-assisted breast biopsy (VABB) and high intensity focused ultrasound (HIFU) for fibroadenoma (FA).

MATERIALS AND METHODS: A total of 162 patients with 267 FAs were enrolled. Baseline characteristics and treatment information were recorded. Patients were followed up at 3-, 6- and 12-month post-treatment. QOL was evaluated by health survey. Breast cosmesis was evaluated by self-rating survey and Harvard Scale. A decision-analytic model was established and incremental cost was calculated for cost-utility analysis.

RESULTS: For QOL evaluation, there was no difference of physical component summary (PCS) score in three groups (P > 0.05), while the mental component summary (MCS) score was significantly higher in HIFU group than the other two groups at 3- and 6-month post-treatment (P < 0.05). The proportion of patients satisfied with breast cosmesis was significantly higher in HIFU group (96.49%) than in VABB group (54.90%) and OS group (49.99%) (P < 0.05). By Harvard Scale, 27.78%, 78.42% and 100.00% of patients were rated as excellent and good in OS group, VABB group and HIFU group, respectively (P < 0.05). To acquire a quality-adjusted life year (QALY), cost of OS, VABB and HIFU was 1034.31 USD, 1776.96 USD and 1277.67 USD, respectively. When compared to OS, incremental cost analysis showed HIFU was cost-effective, while VABB was not.

CONCLUSION: OS, VABB and HIFU were all effective and safe for FA, but among these three treatments, HIFU had the best QOL improvement, breast cosmesis and cost-effectiveness.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Li Z, Yue X, Pan F, et al. A Comparison of Quality of Life, Cosmesis and Cost-Utility of Open Surgery, Vacuum-Assisted Breast Biopsy and High Intensity Focused Ultrasound for Breast Fibroadenoma. Acad Radiol. 2024. PMID: 38637238. doi:10.1016/j.acra.2024.03.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。